Healthcare
BrainScope – SUCCESS PAGE – January 08, 2026
BrainScope is working with the Alzheimer’s Drug Discovery Foundation to to transform how Alzheimer’s is diagnosed and treated
BrainScope is working with the Alzheimer’s Drug Discovery Foundation to to transform how Alzheimer’s is diagnosed and treated
BrainScope is working with the Alzheimer’s Drug Discovery Foundation to to transform how Alzheimer’s is diagnosed and treated
A global, vertically integrated, biopharmaceutical company on a mission to transform the treatment of cancer
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
A global, vertically integrated, biopharmaceutical company on a mission to transform the treatment of cancer
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.